Influence that carnitine replenishment with total parenteral nutrition gives to serum albumin value.
Not Applicable
Completed
- Conditions
- eating disorder,cerebral palsy
- Registration Number
- JPRN-UMIN000003329
- Lead Sponsor
- Shimada Center for Rehabilitation and Neurodevelopmental Intervention, Tama, Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)The allergy to the adjustment powdered milk is possessed. 2)Object person contract a clear acute disease. 3)Doctor is suitable positive.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood calculation and biochemistry inspection (TP, Alb, AST, ALT, T-Bil, BUN, Cre, Tcho.TG, ferritin, transferrin, and thyroid gland function TSH, fT3, fT4, Fe, Cu, Mg, and Zn),free carnitine
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link carnitine supplementation to serum albumin synthesis in TPN-treated cerebral palsy and eating disorder patients?
How does carnitine-enriched TPN compare to standard TPN regimens in improving serum albumin levels for neurodevelopmental and malabsorption-related conditions?
Which biomarkers correlate with serum albumin response to carnitine replenishment in patients with cerebral palsy and anorexia nervosa undergoing TPN?
What are the potential adverse effects of long-term carnitine supplementation in TPN for neurodevelopmental disorders and malnutrition?
Are there synergistic effects of combining carnitine with other amino acids or nutrients in TPN to optimize serum albumin in cerebral palsy and eating disorder populations?